Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 1879-1883

  Danser, A H Jan ^a,e   Derkx, Frans H M ^a   Hense, Hans Werner ^b   Jeunemaître, Xavier ^c   Riegger, Günter A J ^d   Schunkert, Heribert ^d  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Paris Sciences et Lettres   (France)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Polymorphism; Prorenin; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; PRORENIN; RENIN;

ADULT; AGED; ALLELE; ANGIOTENSIN BLOOD LEVEL; CONFERENCE PAPER; DNA POLYMORPHISM; ENZYME BLOOD LEVEL; FEEDBACK SYSTEM; FEMALE; GENOTYPE; GERMANY; HUMAN; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032422586     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00005     Document Type: Conference Paper

References (33)

1. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin-converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592.
2. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
3. Schunkert H, Hense H-W, Holmer S, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 30:1634-1638.
4. Jeunemaître X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
5. Marre M, Jeunemaître X, Gallois Y, Rodier M. Chatellier G, Sert C, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Génétique de la Néphropathie Diabétique (GENEDIAB) Study Group. J Clin Invest 1997; 99:1585-1595.
6. Schunkert H, Hense H-W, Gimenez-Roqueplo AP, Stieber J, Keil U, Riegger GAJ, Jeunemaitre X. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997; 29:628-633.
7. Lindpaintner K, Lee MA, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med 1996; 334:1023-1028.
8. B Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-711.
9. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaître X, Hallouin M-C, Skuppin J, et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14:199-207.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism of the angiotensin I-converting-enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
11. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388.
12. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290:33-40.
13. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25:1266-1269.
14. Lachurié M-L, Azizi M, Guyenne T-T, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91:2933-2942.
15. Chadwick IG, O'Toole L, Morice AH, Yeo WW, Jackson PR, Ramsay LE. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes. J Cardiovasc Pharmacol 1997; 29.485-489.
16. Kurtz A, Scholz H, della Bruna R. Molecular mechanisms of renin release. J Cardiovasc Pharmacol 1990; 16(suppl 4):S1-S7.
17. Derkx FHM, de Bruin RJA, van Gool JMG, van den Hoek M-J, Beerendonck CCM, Rosmalen F, et al. Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem 1996; 42:1051-1063.
18. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin SE, Talsness CE, Dzau VJ. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90:1523-1529.
19. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein C, Lorell BH. Increased rat cardiac angiotensin-converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86:1913-1920.
20. Rigat B, Hubert C, Corvol P. Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20:1433.
21. Staessen JA, Ginocchio G, Wang JG, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk 1997; 4:401-422.
22. Eggena P, Barrett JD. Regulation and functional consequences of angiotensinogen gene expression. J Hypertens 1992; 10:1307-1311.
23. Schunkert H, Danser AHJ, Hense H-W, Derkx FHM, Kürzinger S. Riegger GAJ. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997; 95:39-45.
24. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K. Bunker RK, Mao YP, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991; 67:213-224.
25. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 1997; 99:2375-2385.
26. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi M-A, Hemingway H, et al. Association of angiotensin-converting enzyme gene IID polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96:741-747.
27. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17:787-794.
28. Admiraal PJJ, Danser AHJ, Jong MS, Pieterman H, Derkx FHM, Schalekamp MADH. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993; 21:173-184.
29. van Kats JP, Danser AHJ, van Meegen JR, Sassen LMA, Verdouw PD, Schalekamp MADH. Angiotensin production by the heart. A quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 1998; 98:73-81.
30. Danser AHJ, Derkx FHM, Schalekamp MADH, Hense H-W, Riegger GAJ, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998; 16:853-862.
31. Jeunemaître X, Inoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60:1448-1460.
32. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 1997; 30:1325-1330.
33. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997; 29:1078-1082.